Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells

per Thaler, Sonja, Schmidt, Marcus, Roβwag, Sven, Thiede, Gitta, Schad, Arno, Sleeman, Jonathan P
Publicat a Oncotarget (2017)